特发性膜性肾病—培训课件.pptVIP

Rituximab treatment of idiopathic membranous nephropathy Fervenza FC Division of Nephrology and Hypertension, Mayo Clinic, USA —— Kidney Int. 2008 Jan 类似的研究结果： Tacrolimus(他克莫司)monotherapy in membranous nephropathy: a randomized controlled trial. Praga M, Madrid, Spain —— Kidney Int. 2007 May 25 patients received tacrolimus (0.05 mg/kg/day) over 12 months with a 6-month taper, 23 patients were in the control group. The probability of remission 50% increase in SCr 6months 12mo